Top bio­phar­ma ex­ecs of­fer scare tac­tics and mixed mes­sages on drug pric­ing bills mak­ing their way to Capi­tol Hill

Top bio­phar­ma ex­ecs from Mer­ck, Eli Lil­ly, Take­da and in­dus­try lob­by­ing group PhRMA tried their best to per­suade the me­dia Wednes­day that drug price ne­go­ti­a­tion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER